5YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
XL147 | XL147 | 956958-53-5 |
GSK-3787 | GSK-3787 | 188591-46-0 |
ETP-46321 | CS-2500 | 1252594-99-2 |
EPZ015666 | EPZ015666 | 1616391-65-1 |
Lasmiditan hemisuccinate | 琥珀酸拉斯米迪坦 | 439239-92-6 |
Lasmiditan hydrochloride | 613677-28-4 | 613677-28-4 |
Afatinib | 阿法替尼 | 439081-18-2 |
Brivanib alaninate | 1-[[4-[(4-氟-2-甲基-1H-吲哚-5-基)氧基]-5-甲基吡咯并[2,1-F][1,2,4]三嗪-6-基]氧基]-2-丙醇 L-丙氨酸酯 | 649735-63-7 |
Cediranib maleate | 西地尼布马来酸盐 | 857036-77-2 |
Lu AE58054 HCl salt | N-[2-(6-氟-1H-吲哚-3-基)乙基]-3-(2,2,3,3-四氟丙氧基)苄基胺单盐酸盐 | 467458-02-2 |
LY-900009 | LY900009 | 209984-68-9 |
AZ5104 | 奥西替尼中间体 | 1421373-98-9 |
SU 5205 | SU 5205; SU-5205; SU5205 | 3476-86-6 |
Lusutrombopag | 芦曲泊帕 | 1110766-97-6 |
Methyl 2,5-dihydroxycinnamate | 2,5-二羟基肉桂酸甲酯 | 63177-57-1 |
Obatoclax mesylate | Obatoclax 甲磺酸盐 | 803712-79-0 |
Mubritinib | 木利替尼 | 366017-09-6 |
Rostafuroxin | ROSTAFUROXIN | 156722-18-8 |
Tertiapin | tertiapin | 58694-52-3 |
Lavendustin A | 薰草菌素 | 125697-92-9 |
Vatalanib | 瓦他拉尼碱 | 212141-54-3 |
AZD-8931 | AZD8931 | 848942-61-0 |
HMN-214 | (E)-4-[2-[2-[N-乙酰基-N-[(4-甲氧基苯基)磺酰]氨基]苯基]乙烯基]吡啶 1-氧化物 | 173529-46-9 |
UNC-0638 | UNC0638 | 1255580-76-7 |
Icotinib hydrochloride | 凯美纳 | 1204313-51-8 |
AZD9291DA | AZD9291中间体1 | 1421372-66-8 |
Fruquintinib | 呋喹替尼 | 1194506-26-7 |
E7046 | E-7046 | 1369489-71-3 |
Almotriptan Malate | 依来曲普坦 | 181183-52-8 |
DSP-6952 hydrobromide | Minesapride | 1184661-33-3 |
Asenapine maleate | 阿塞那平马来酸盐 | 85650-56-2 |
Zibotentan | 齐泊腾坦 | 186497-07-4 |
Eltoprazine hydrochloride | 1-(2,3-二氢苯并[B][1,4]二氧杂芑-5-基)哌嗪 | 98206-09-8 |
SU5408 | VEGFR2 KISE INHIBITOR I | 15966-93-5 |
Quinine hemisulfate dihydrate | 硫酸奎宁 | 6119-70-6 |
Irbinitinib | 妥卡替尼 | 937263-43-9 |
IOX2 | IOX 2 | 931398-72-0 |
17-Phenyl Trinor Prostaglandin F2α Methyl Amide | 比马前列素甲胺 | 155206-01-2 |
AZD8186 | 8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 | 1627494-13-6 |
AG-1557 | AG-1557 | 189290-58-2 |
JK-P3 | 3,4-二甲氧基-N-(5-苯基-1H-吡唑-3-基)苯甲酰胺 | 942655-44-9 |
EGF816 | EGF816 | 1508250-71-2 |
EPZ015866 | GSK591 (EPZ-015866) | 1616391-87-7 |
Lanifibranor | IVA-337 | 927961-18-0 |
PD123319 | PD 123319 | 130663-39-7 |
Cediranib dihydrochloride | 西地尼布 | 288383-20-0 |
GDC0941 | GDC-0941 | 957054-30-7 |
Darusentan | 达卢生坦 | 171714-84-4 |
Palosuran | ACT 058362; PALOSURAN, | 540769-28-6 |
CPI-444 | CPI-444 | 1202402-40-1 |
Elafibranor | GFT505 | 923978-27-2 |
SU 4942 | SU 4942; SU-4942; SU4942 | 76086-99-2 |
hVEGF-IN-1 | 1637443-98-1 | 1637443-98-1 |
KNK437 | KNK437 | 218924-25-5 |
AV-412 | AV-412 | 451492-95-8 |
WZ-4002 | WZ4002 | 1213269-23-8 |
Rigosertib sodium | N-[2-甲氧基-5-[[[2-(2,4,6-三甲氧基苯基)乙烯基]磺酰]甲基]苯基]甘氨酸钠盐 | 1225497-78-8 |
GW 627368X | GW627368X | 439288-66-1 |
Copanlisib | 库潘尼西 | 1032568-63-0 |
Regorafenib Hydrochloride | 瑞格非尼盐酸盐 | 835621-07-3 |
Regorafenib monohydrate | 瑞格非尼一水合物 | 1019206-88-2 |
Naquotinib | NAQUOTINIB | 1448232-80-1 |
CID5721353 | 301356-95-6 | 301356-95-6 |
AG 1406 | AG1406;AG-1406 | 71308-34-4 |
AVN-492 | CS-2812 | 1220646-23-0 |
GW3965 Hydrochloride | 2-[3-[3-[[2-氯-3-(三氟甲基)苄基](2,2-二苯基乙基)氨基]丙氧基]苯基]乙酸盐酸盐 | 405911-17-3 |
AS-604850 | 5-[(2,2-二氟-1,3-苯并二恶茂-5-基)亚甲基]噻唑烷-2,4-二酮 | 648449-76-7 |
Oglufanide | H-GLU-TRP-OH | 38101-59-6 |
GlyH-101 | GLYH 101 | 328541-79-3 |
GSK-461364 | GSK461364 | 929095-18-1 |
Umbralisib | TGR-1202 | 1532533-67-7 |
3-Methyltoxoflavin | 3-methyl toxoflavin | 32502-62-8 |
MS023 | N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺 | 1831110-54-3 |
MSDC-0602 | 1133819-87-0 | 1133819-87-0 |
Vortioxetine HBr | 氢溴酸沃替西汀 | 960203-27-4 |
XL 765 | XL765 | 1349796-36-6 |
UNC1215 | UNC1215 | 1415800-43-9 |
Pilaralisib | 2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 | 934526-89-3 |
Mutant EGFR inhibitor | N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺 | 1421373-62-7 |
GS967 | GS967 | 1262618-39-2 |
MDK34597 | PIK抑制剂 | 371934-59-7 |
Vabicaserin hydrochloride | VABICASERIN HYDROCHLORIDE | 887258-94-8 |
Cloprostenol sodium | 氯前列烯醇钠 | 55028-72-3 |
Tivozanib | 替沃扎尼 | 475108-18-0 |
AC-55541 | AC-55541 | 916170-19-9 |
Preladenant | 瑞德南特 | 377727-87-2 |
Icotinib | 埃克替尼 | 610798-31-7 |
EAI045 | EAI-045 | 1942114-09-1 |
BMS-779788 | 化合物XL652 | 918348-67-1 |
WAY-100635 maleate | WAY-100635 | 634908-75-1 |
Naronapride dihydrochloride | CS-632 | 860169-57-9 |
Semaxanib | SU5416 | 204005-46-9 |
SB-3CT | SB-3CT | 292605-14-2 |
Brivanib | 酪氨酸激酶抑制剂 | 649735-46-6 |
SB742457 | 3-苯基磺酰基-8-(哌嗪-1-基)喹啉 | 607742-69-8 |
PIK 75 hydrochloride | 2-甲基-5-硝基苯磺酸 [(6-溴咪唑并[1,2-A]吡啶-3-基)亚甲基]甲基肼盐酸盐 | 372196-77-5 |
CL-387785 | CL-387785 | 194423-06-8 |
CNX-2006 | CNX2006 | 1375465-09-0 |
VPS34-IN1 | VPS34-IN1 | 1383716-33-3 |
3-Methyladenine | 6-氨基-3-甲基嘌呤 | 5142-23-4 |
联系方式
电话:-+1-631-485-4226
邮箱:inquiry@bocsci.com
网址: https://www.bocsci.com/
产品总数: 19553
地址:
CB指数:58
国籍:美国